ChromaCure
Gosselies · Founded 2018
About ChromaCure
ChromaCure will launch a drug development program to identify potential new candidates that selectively and potently inhibit cancer targets and potentially provide novel therapy for multiple forms of cancer, either as monotherapy or in combination with immunotherapy or chemotherapy.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $19.6M
- Last round: Series Unknown (May 2018)
- Website: http://www.chromacure.com
Industries & Categories
Life Science, Medical Device, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/chromacure-158715 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.